• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ortin Global Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 17472.0
  • ISIN : INE749B01020
9.80 0 (0.10%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    9.64

  • Today’s High

    10.23

  • Open

    9.89

  • Perv Close

    9.79

  • 52W Low

    9.64

  • 52W High

    24.82

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    7.97

  • Div & Yield %

    0.00

  • Book Value(₹)

    2.77

  • Debt-Equity Ratio

    0.10

  • AGM Date

    28-Mar-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    7.97

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    8.13

  • BV (₹)

    2.80

  • Sales( ₹ in Cr.)

    2.11

  • NP (in Cr.)

    -6.28

  • NP Var(%)

    -8201.0

  • Div%

    0.0

  • CPS (₹)

    -7.40

  • EPS (₹)

    -7.70

  • Traded Value (₹ in Lakhs)

    8.12

  • 52 Week High

    24.82

  • 52 Week Low

    9.64

  • Price BSE

    10.0

  • Price NSE

    10.00

  • Market Capital( in Cr.)

    8.12

  • P/C Ratio

    -1.30

  • P/E Ratio

    -1.30

  • Price Vs.BV

    -7.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 2.11 6.02 8.23 8.17 197.39 167.76
Excise Duty 2.11 6.02 8.23 8.17 196.16 163.26
Net Sales 2.11 6.02 8.23 8.17 197.39 167.76
Other Income 0.17 0.04 0.19 0.05 0.19 0.13
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 2.28 6.06 8.43 8.22 197.58 167.89
EXPENDITURE :
Raw Materials 2.11 6.02 8.23 8.17 196.16 163.26
Power & Fuel Cost 2.11 6.02 8.23 8.17 196.16 163.26
Employee Cost 0.56 0.85 0.95 1.05 5.36 4.25
Other Manufacturing Expenses 2.48 0.17 0.41 0.40 1.60 1.34
Selling & Administrative Expenses 1.29 0.71 1.25 1.06 5.27 2.84
Miscellaneous Expenses 2.48 0.17 0.41 0.40 1.60 1.34
Less : Pre-operative Expenses Capitalised :
Total Expenditure 9.36 6.15 8.96 8.08 196.86 166.05
Operating Profit 0.61 0.39 0.59 0.46 24.85 17.83
Interest 0.48 0.40 0.81 0.87 3.21 3.22
Gross Profit -7.08 -0.11 -0.53 0.14 0.72 1.84
Depreciation 0.23 0.25 0.29 0.29 1.96 1.75
Profit Before Tax -7.08 -0.11 -0.53 0.14 0.72 1.84
Tax 1.29 0.00 0.00 0.06 0.22 0.50
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.33 -0.02 -0.13 -0.87 0.23 0.02
Reported Net Profit -8.04 -0.09 -0.40 0.95 -0.56 1.28
Extraordinary Items -7.08 -0.11 -0.53 0.14 0.72 1.84
Adjusted Net Profit -8.04 -0.09 -0.40 0.95 -0.56 1.28
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -8.04 -0.09 -0.40 0.95 -0.56 1.28
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -9.89 -0.12 -0.49 1.16 -0.33 0.76
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    1.23%

  • Public Share Holding

    98.77%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 100,300 1.23 100,300 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 100,300 1.23 100,300 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 507,839 6.25 507,839 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 507,839 6.25 507,839 2
2] Non Institution
Bodies Corporate 399,474 4.91 398,610 43
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 92,467 1.14 92,467 57
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 179,948 2.21 179,468 190
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,872,814 23.03 1,790,614 29
Individuals holding nominal share capital up to Rs. 1 lakh 4,978,550 61.23 4,978,550 11,769
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,523,253 92.52 7,439,709 12,088
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 8,131,392 100.00 8,047,848 12,094

Company Background

Ortin Global LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Ortin Global Ltd
  • BSE Code : 17472.0
  • ISIN : INE749B01020

  • Incorporation Year

    1986

  • Registered Office

    D No 1-8-B4 Ground Floor F3
    HIG Block-4 Street No 3, Hyderabad,
    Telangana-500044

  • Telephone

  • FAX

  • Chairman

    J R K Panduranga Rao

  • Managing Director

    S Murali Krishna Murthy

  • Company Secretary

  • Auditor

    Mathesh & Ramana

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Ortin Global Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ortin Global 9.98 2.28 2.11 -1.68 0.00
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92